Back
BioCryst Pharmaceuticals Stock Price Chart
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
BCRX
BioCryst Pharmaceuticals
Last Price:
8.25
Seasonality Move:
-9.69%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.
BioCryst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.82 | Buy |
| 20-day SMA: | 8.08 | Sell |
| 50-day SMA: | 7.71 | Buy |
| 200-day SMA: | 6.17 | Buy |
| 8-day EMA: | 7.92 | Buy |
| 20-day EMA: | 7.94 | Buy |
| 50-day EMA: | 7.62 | Buy |
| 200-day EMA: | 6.76 | Buy |
BioCryst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 52.47 | Buy |
| Chaikin Money Flow: | -1073813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.73 - 8.31) | Sell |
| Bollinger Bands (100): | (5.79 - 7.89) | Buy |
BioCryst Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioCryst Pharmaceuticals Stock
Is BioCryst Pharmaceuticals Stock a Buy?
- BioCryst Pharmaceuticals share price is 7.97 while BCRX 8-day simple moving average is 7.82, which is a Buy signal.
- The stock price of BCRX is 7.97 while BioCryst Pharmaceuticals 20-day SMA is 8.08, which makes it a Sell.
- BioCryst Pharmaceuticals 50-day simple moving average is 7.71 while BCRX share price is 7.97, making it a Buy technically.
- BCRX stock price is 7.97 and BioCryst Pharmaceuticals 200-day simple moving average is 6.17, creating a Buy signal.
BCRX Technical Analysis vs Fundamental Analysis
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy or a Sell?
-
BioCryst Pharmaceuticals stock is rated a Sell
The current BioCryst Pharmaceuticals [BCRX] share price is $7.97. The Score for BCRX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
BioCryst Pharmaceuticals Stock Info
Market Cap:
1.65B
Price in USD:
7.97
Share Volume:
1.67M
BioCryst Pharmaceuticals 52-Week Range
52-Week High:
8.88
52-Week Low:
4.03
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
BioCryst Pharmaceuticals Share Price Forecast
-
What is the BioCryst Pharmaceuticals stock price today?
The BioCryst Pharmaceuticals stock price is 7.97 USD today. -
Will BCRX stock go up or go down?
BioCryst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is BioCryst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioCryst Pharmaceuticals is overvalued.
Is BioCryst Pharmaceuticals Stock a Buy?
- BioCryst Pharmaceuticals share price is 7.97 while BCRX 8-day exponential moving average is 7.92, which is a Buy signal.
- The stock price of BCRX is 7.97 while BioCryst Pharmaceuticals 20-day EMA is 7.94, which makes it a Buy.
- BioCryst Pharmaceuticals 50-day exponential moving average is 7.62 while BCRX share price is 7.97, making it a Buy technically.
- BCRX stock price is 7.97 and BioCryst Pharmaceuticals 200-day simple moving average is 6.76, creating a Buy signal.
Fundamental Analysis of BioCryst Pharmaceuticals
Is BioCryst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.23 per share.
Technical Analysis of BioCryst Pharmaceuticals
Should I short BioCryst Pharmaceuticals stock?
- BCRX Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting BioCryst Pharmaceuticals is a Buy
- BioCryst Pharmaceuticals Relative Strength Index (RSI) is 52.47, which suggest BioCryst Pharmaceuticals is overbought
- The Bollinger Bands (25) for BioCryst Pharmaceuticals is (7.73 - 8.31), which suggest BioCryst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for BioCryst Pharmaceuticals is (5.79 - 7.89), which suggest BioCryst Pharmaceuticals is a Buy
* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.